Abnormality of SSEPs, Exercise, Hyperalgesia, Motor Activity, Nerve Growth Factor
Conditions
Brief summary
The purpose of this study is to investigate the sensory-motor cortical excitability response to delayed onset muscle soreness (DOMS) on Extensor Carpi Radialis (ECR) muscle during muscle hyperalgesia provoked by nerve growth factor (NGF).
Detailed description
The purpose of this study is to assess changes in sensory-motor cortical excitability during experimental muscle hyperalgesia across several days provoked by injections of nerve growth factor (NGF) into the Extensor Carpi Radialis (ECR) muscle and delayed onset muscle soreness (DOMS) of the ECR muscle. It was hypothesized that muscle hyperalgesia across several days would result in: i) Increased sensory cortical excitability, based on somatosensory evoked potentials by means of electrical stimulation of the radial nerve, (increase of central-parietal evoked-potential P45 and decrease of frontal evoked-potential N30); ii) Increased corticomotor excitability of a ECR (increase map volume and number of active sites), assessed as motor evoked potentials induced by transcranial magnetic stimulation in primary motor cortex (M1); iii) Reduction of alpha oscillation based on nociceptive stimulus-evoked suppression of alpha activity in sensory regions (recording electrodes on contra-lateral parietal area);
Interventions
DRUGSterile solutions of recombinant human nerve growth factor (NGF)
The intramuscular injections of NGF cause muscle soreness.
Sponsors
Aalborg University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Healthy men and women * Speak and understand English.
Exclusion criteria
Pregnancy * Drug addiction defined as the use of cannabis, opioids or other drugs * Previous neurologic, musculoskeletal or mental illnesses * Lack of ability to cooperate * History of chronic pain or current acute pain * Previous experience with rTMS * Contraindications to rTMS application (history of epilepsy, metal in the head or jaw etc.). * Failure to pass the TASS questionnaire (TASS = Transcranial Magnetic Stimulation Adult Safety Screen)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain rating | Change from baseline at 2 weeks | Pain on an 11-point numerical rating scale (0 = no pain, 10 = most intense pain imaginable) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Muscle soreness | Change from baseline at 2 weeks | 7-point Likert scale; 0 = 'a complete absence of soreness', 1 = 'a light soreness in the muscle felt only when touched/vague ache', 2 = 'a moderate soreness felt only when touched/a slight persistent ache', '3 = 'a light muscle soreness when lifting or carrying objects', 4 = 'a light muscle soreness, stiffness or weakness when moving the wrist without gripping an object', 5 = 'a moderate muscle soreness, stiffness or weakness when moving the wrist', 6 = 'a severe muscle soreness, stiffness or weakness that limits the ability to move' |
| Patient-rated Tennis Elbow Evaluation | Change from baseline at 2 weeks | The Patient-rated Tennis Elbow Evaluation will be used to assess average pain and disability of the injected arm |
| Alpha oscillations | Change from baseline at 1 weeks | Continuous EEG recording |
| Motor evoked potentials | Change from baseline at 1 week | Transcranial magnetic stimualtion will be used to evoke motor evoked potentials (MEPs) to the extensor carpi radialis muscle |
| Sensory evoked potentials | Change from baseline at 1 week | EEG recodring |
| Pressure pain thresholds | Change from baseline at 2 weeks | Pressure applied to the surface of the skin using a handheld algometer. |
Countries
Denmark
Outcome results
None listed